We are live on ! Find out more
CIA

Capital Impact Advisors Portfolio holdings

AUM $247M
1-Year Est. Return 31.15%
This Fund
S&P 500
This Quarter Est. Return
-9.19%
1 Year Est. Return
+31.15%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$138M
AUM Growth
-$7.43M
Cap. Flow
+$9.14M
Cap. Flow %
6.65%
Top 10 Hldgs %
13.44%
Holding
199
New
102
Increased
30
Reduced
53
Closed
12

Top Buys

Rank Stock Value
1
OMCL icon
Omnicell
OMCL
+$2.11M
2
NVDA icon
NVIDIA
NVDA
+$1.99M
3
UPST icon
Upstart Holdings
UPST
+$1.33M
4
CLH icon
Clean Harbors
CLH
+$1.13M
5
SSTK icon
Shutterstock
SSTK
+$1.07M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$4.88M
2
MSFT icon
Microsoft
MSFT
+$4.2M
3
AMZN icon
Amazon
AMZN
+$3.87M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$3.58M
5
SNPS icon
Synopsys
SNPS
+$2.45M

Sector Composition

Rank Sector Weight
1 Technology 29.61%
2 Healthcare 24.32%
3 Consumer Discretionary 11.69%
4 Industrials 9.16%
5 Financials 8.29%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PI icon
101
Impinj
PI
$4.62B
$664K 0.48%
10,451
-3,919
-27% -$283K
SHAK icon
102
Shake Shack
SHAK
$2.53B
$654K 0.48%
+9,625
New +$662K
SBUX icon
103
Starbucks
SBUX
$120B
$653K 0.47%
+7,177
New +$677K
SEM
104
DELISTED
Select Medical
SEM
$653K 0.47%
+50,491
New +$667K
BLMN icon
105
Bloomin' Brands
BLMN
$741M
$650K 0.47%
29,633
-2,550
-8% -$55K
AGNT
106
AGNT Inc
AGNT
$666M
$647K 0.47%
30,584
-27,864
-48% -$730K
AMPH icon
107
Amphastar Pharmaceuticals
AMPH
$879M
$638K 0.46%
+17,760
New +$504K
FNV icon
108
Franco-Nevada
FNV
$41.1B
$634K 0.46%
+3,972
New +$572K
TITN icon
109
Titan Machinery
TITN
$396M
$632K 0.46%
+22,362
New +$678K
SGEN
110
DELISTED
Seagen Inc. Common Stock
SGEN
$621K 0.45%
4,314
-11,361
-72% -$1.54M
EPAM icon
111
EPAM Systems
EPAM
$5.51B
$617K 0.45%
2,079
-502
-19% -$197K
SSNC icon
112
SS&C Technologies
SSNC
$18.1B
$608K 0.44%
8,108
-10,233
-56% -$800K
ZM icon
113
Zoom
ZM
$28.2B
$603K 0.44%
+5,147
New +$700K
MTCH icon
114
Match Group
MTCH
$9.19B
$601K 0.44%
+5,531
New +$611K
IPAR icon
115
Interparfums
IPAR
$3.99B
$599K 0.44%
6,799
-5,597
-45% -$517K
NTLA icon
116
Intellia Therapeutics
NTLA
$1.49B
$596K 0.43%
8,200
+3,338
+69% +$283K
NVTA
117
DELISTED
Invitae Corporation
NVTA
$594K 0.43%
+74,591
New +$750K
ONEW icon
118
OneWater Marine
ONEW
$204M
$593K 0.43%
+17,203
New +$829K
STLD icon
119
Steel Dynamics
STLD
$36B
$590K 0.43%
+7,073
New +$477K
CRM icon
120
Salesforce
CRM
$151B
$587K 0.43%
+2,763
New +$595K
PLMR icon
121
Palomar
PLMR
$3.55B
$585K 0.43%
+9,141
New +$519K
HLI icon
122
Houlihan Lokey
HLI
$8.77B
$578K 0.42%
6,586
-5,351
-45% -$551K
TTD icon
123
Trade Desk
TTD
$8.48B
$578K 0.42%
+8,350
New +$603K
EXEL icon
124
Exelixis
EXEL
$13.3B
$571K 0.42%
+25,182
New +$492K
AN icon
125
AutoNation
AN
$7.11B
$565K 0.41%
5,678
+1,764
+45% +$195K

Similar funds

Capital Impact Advisors's Q1 2022 Portfolio in Review

As of Q1 2022, Capital Impact Advisors held 199 positions worth $138M, down 5.1% from $145M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Capital Impact Advisors deployed $9.14M of net new capital in Q1 2022, opening 102 new positions and adding to 30 existing holdings. Its largest new stake was Omnicell: 14,606 shares worth $1.89M.

By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was Apple, an estimated $4.88M trimmed.

  • Capital Impact Advisors's largest Q1 2022 buy was Omnicell: 14,606 shares worth $1.89M.
  • Capital Impact Advisors added most to e.l.f. Beauty in Q1 2022, an estimated $853K increase.
  • Capital Impact Advisors's biggest Q1 2022 reduction was Apple, cutting an estimated $4.88M.
  • Capital Impact Advisors fully exited Medpace in Q1 2022, selling an estimated $1.89M.
  • Capital Impact Advisors's ten largest holdings make up 13% of its $138M portfolio in Q1 2022.
  • Capital Impact Advisors opened 102 new positions and closed 12 in Q1 2022.
  • Capital Impact Advisors's portfolio value fell 5.1% quarter-over-quarter to $138M.

Based on Capital Impact Advisors's 13F filing for Q1 2022, filed 16 May 2022.